- Health Horizon Herald
- Posts
- 02/13/25 - #326
02/13/25 - #326

Good morning. In today’s edition:
Eating Just One Egg a Week Could Be Enough to Lower Your Risk of Dying From Heart Disease
Eli Lilly to Release Late-stage Data on Next-generation Weight Loss Drug Retatrutide in 2025, Earlier Than Expected
FDA Approves New Type of Nonopioid Painkiller for Acute Pain
Power Naps or Productivity Hacks? Devoted Nap-takers Explain the Benefits of Sleeping on the Job
…and lots more. Have a great day!
Fast-Acting Relief for Day and Night
The world’s first fast-acting, targeted pain relief edible
AM formula for active days without drowsiness
PM formula for restorative nights and better rest
FOOD & NUTRITION
Eating Just One Egg a Week Could Be Enough to Lower Your Risk of Dying From Heart Disease

Eating between one and six eggs a week could lower the risk of heart-related deaths for older adults. This finding comes from a study by Monash University in Australia, which looked at over 8,700 people who are 70 or older.
The study found that those who ate up to six eggs each week had a 15% lower chance of dying from any cause compared to those who ate eggs less often. They also had a 29% lower chance of dying from heart disease.
Eggs are full of important nutrients that help keep our bodies working well as we age. They have a lot of protein, B vitamins, and minerals. Even though people have been worried about eating eggs because of cholesterol, this study shows that eggs might be safer for heart health than we thought, even for those watching their cholesterol.
The research also included people with high cholesterol. Those who ate eggs regularly had a 27% lower risk of dying from heart disease compared to those who didn't eat eggs often. This suggests that eating eggs might be okay for people with cholesterol issues too.
Recent guidelines from the American Heart Association say that eating up to seven eggs a week is safe for healthy people. So, for older adults, having an egg or two every week might be a simple way to help keep the heart healthy.
|
WEIGHT LOSS
Eli Lilly to Release Late-stage Data on Next-generation Weight Loss Drug Retatrutide in 2025, Earlier Than Expected

Eli Lilly, a big name in medicine, is bringing exciting news about its new weight loss drug, retatrutide. They plan to share important information in 2025, which is earlier than they first thought. This news was shared during their latest earnings report and has caught the attention of many.
Retatrutide is being tested to see how well it helps people with obesity and knee problems caused by arthritis. The study, lasting 68 weeks, looks at whether this drug can help people lose weight and feel better in their joints. Retatrutide may change obesity treatment. It works differently by targeting three hormones that control hunger.
This drug mimics the hormones GLP-1, GIP, and glucagon. These hormones help control how hungry you feel and how satisfied you are after eating. Retatrutide may work better than other drugs, like tirzepatide and Wegovy from Novo Nordisk. Those drugs don’t target as many hormones.
In a previous study, retatrutide helped people lose about 24.2% of their body weight, which is around 58 pounds, in just 48 weeks. This was more weight loss than what was seen with tirzepatide in similar studies.
Eli Lilly is set to share more data next year. Many are hopeful that retatrutide will be a powerful new choice for weight management and better health.
HEALTH
FDA Approves New Type of Nonopioid Painkiller for Acute Pain

On January 31, 2025, the FDA approved a new nonopioid painkiller called Journavx, made by Vertex Pharmaceuticals. This drug, also known as suzetrigine, treats moderate to severe short-term pain in adults and doesn't lead to addiction like opioids do.
Journavx works differently from opioids. It stops pain signals from reaching the brain by blocking certain pathways. This could make it a great choice for managing pain without the risk of becoming addicted.
In trials, Journavx was tested on patients who had surgeries such as tummy tucks and bunion removals. It reduced their pain by about half, which is similar to the relief opioids provide but often with fewer side effects. The most common side effects included headaches, nausea, and constipation. However, they were usually milder than those from opioids.
Doctors are excited about this new drug. It provides a safer option for managing severe pain, especially for patients who can't use other medications. However, they also say that more research is needed to fully understand how well it works and how safe it is over time.
Journavx represents a big change in treating pain. It could reduce the use of opioids, which are effective but can lead to addiction. As this new drug becomes available, it will be watched closely to see how well it helps patients manage pain safely.
Power Naps or Productivity Hacks? Devoted Nap-takers Explain the Benefits of Sleeping on the Job

In our busy lives, it's hard to stay energetic all day, especially for those of us over 45. What if a quick nap could help us get more done? Many people who take short naps at work say it really boosts their work performance.
A power nap lasts about 20 minutes and can refresh your brain. Research shows that a quick sleep can greatly improve how well we think, remember, and solve problems.
John, 58, an account manager, has taken power naps during lunch for five years. "It’s like hitting the reset button. I wake up clear-headed and in a better mood," he says.
Susan, 52, a project coordinator, agrees. "After a quick nap, handling tough tasks gets easier. It’s a big help for my work."
Not all workplaces are okay with napping. If you can't nap at work, just closing your eyes for a few minutes in a quiet spot can also help.
Adding power naps to our workday isn't just about getting more sleep. It’s about using our awake time better. As more workers try this simple trick, it might become more common in offices everywhere. So, if you feel tired, think about taking a power nap. It could be just what you need to get more done.
✢ A Note From Hem Hero
The information in this health newsletter is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment; always consult your healthcare provider with any questions or concerns you may have regarding your health. The publishers are not responsible for any actions taken by the reader based on the information provided.